Background Neuroleptic malignant syndrome (NMS) is a rare, severe, idiosyncratic adverse
reaction to antipsychotics. Second-generation antipsychotics (SGAs) were originally …

Objective: To review evidence for the treatment of neuroleptic malignant syndrome (NMS)
and to discuss how to rechallenge patients with neuroleptics when continued …

Neuroleptic malignant syndrome is an unpredictable iatrogenic neurologic emergency
condition, mainly arising as an idiosyncratic reaction to antipsychotic agent use. It is …

Elevation in core body temperature is one of the most frequently detected abnormal signs in
patients admitted to adult ICUs, and is associated with increased mortality in select …

Objective To investigate the association between neuroleptic malignant syndrome (NMS)
and levels of antipsychotic exposure. Method Electronic health record data systematically …

Many acute and potentially life-threatening medical conditions have hyperkinetic or
hypokinetic movement disorders as their hallmark. Here we review the clinical …

Serotonin syndrome and neuroleptic malignant syndrome are two drug toxidromes that have
often overlapping and confusing clinical pictures. We report a case of a young man who …

Objective: To describe patients with neuroleptic malignant syndrome (NMS), to establish
occurrence of NMS, to investigate risk factors of NMS, and to investigate mortality associated …

Key Points Neuroleptic Malignant Syndrome Neuroleptic malignant syndrome is
characterized by fever, muscular rigidity, and dysautonomia after exposure to dopamine …

Drug-induced movement disorders (DIMDs) are most commonly associated with typical and
atypical antipsychotics. However, other drugs such as antidepressants, antihistamines …